T2* mapping can be a potential biomarker to characterise hypoxia and monitor treatment response throughout the course of MR-guided radiotherapy on an MR-Linac. This study explores the feasibility of integrating T2* mapping in daily prostate MR-Linac workflow using a cohort of patients with prostate cancer. We compared mean T2* values within the prostate with repeated measures acquired twice weekly during radiotherapy. T2* values at the end of treatment were higher than at the first fraction but didn’t show a consistent trend throughout treatment. Integrating T2* mapping with other functional measurements can aid in response based treatment adaptation.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords